Order the just-launched Galaxy Fold7, Flip7, or Watch8 Classic – New deal Galaxy S25 Ultra
Last updated: September 20th, 2021 at 10:18 UTC+02:00
SamMobile has affiliate and sponsored partnerships, we may earn a commission.
Reading time: 2 minutes
Back in May, Moon and U.S. President Biden reached a joint vaccine development agreement between the two countries. One that's expected to be detailed this week, following a singing ceremony which Moon will attend. Either way, the partnership is at the heart of a $2-billion investment plan meant to position South Korea as Asia's largest vaccine production hub.
Unsurprisingly, Samsung is meant to play an integral role in this R&D push. And in this instance, “Samsung” refers to Samsung Biologics, a Songdo, Incheon-based biotechnology unit of Samsung Group. The Korean side of the deal also includes the manufacturing capabilities of SK Bioscience, as per today's report.
Apart from vaccine production, the chaebol has also been involved in combating the global pandemic on other fronts. For example, it was only last month that it introduced a way for Samsung Pay users to store their digital vaccine credentials on their devices. The feature, developed alongside the Commons Project Foundation, started rolling out globally in early September.
But in order to take advantage of it, you first have to become a CommonHealth user. And judging by the latter's abysmal Play Store reviews, many are still struggling with getting it to work.
Trending
We'd like to show you notifications for the latest important news and updates